2017
DOI: 10.1097/01.ogx.0000524508.40309.08
|View full text |Cite
|
Sign up to set email alerts
|

Live Birth Derived From Oocyte Spindle Transfer to Prevent Mitochondrial Disease

Abstract: (Abstracted from Reprod Biomed 2017;34:361–368) It is estimated that at least 1 in 5000 people in the general population has 1 mutation in mitochondrial DNA (mtDNA), which can cause maternally inherited mitochondrial disorders. When both mutant mitochondrial and wild-type (normal) genomes coexist (heteroplasmy), the severity of symptoms is associated with the level of mtDNA mutation load or degree of heteroplasmy.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
38
0
5

Year Published

2017
2017
2022
2022

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 26 publications
(43 citation statements)
references
References 0 publications
0
38
0
5
Order By: Relevance
“…These NT technologies appear to be efficient in terms of embryonic development and safe in terms of minimal mtDNA carryover (Yamada et al, 2016;Hyslop et al, 2016). In April 2016, the first child resulting from maternal spindle transfer was born (Zhang et al, 2017).The mother was an asymptomatic carrier of a mitochondrial mutation that caused Leigh syndrome, a fatal neurological disorder. The child, who has 1% of its mother's mtDNA, was healthy at three months, although it is not known if any abnormality might appear later on.…”
Section: Genome Editing In the Mtdnamentioning
confidence: 99%
“…These NT technologies appear to be efficient in terms of embryonic development and safe in terms of minimal mtDNA carryover (Yamada et al, 2016;Hyslop et al, 2016). In April 2016, the first child resulting from maternal spindle transfer was born (Zhang et al, 2017).The mother was an asymptomatic carrier of a mitochondrial mutation that caused Leigh syndrome, a fatal neurological disorder. The child, who has 1% of its mother's mtDNA, was healthy at three months, although it is not known if any abnormality might appear later on.…”
Section: Genome Editing In the Mtdnamentioning
confidence: 99%
“…Neither fetus had detectable levels of the maternal (karyoplast-derived) mtDNA haplotype. In addition, the use of MST to treat a case of Leigh syndrome has been reported 46 . Transfer of an XY euploid blastocyst following MST resulted in a live birth.…”
Section: Mrt In Humans: Research and Clinical Applicationsmentioning
confidence: 99%
“…The sensitivity that surrounds clinical use of MRT was exemplified by the media interest in the UK HFEA's decision to license a clinic to perform MRT (https://www.hfea.gov.uk/about-us/news-and-pressreleases/2017-news-and-press-releases/hfea-statement-on-mitochondrial-donation/) and the birth of a child following treatment in a clinic in Mexico 46 . A number of challenges have been made to MRT on legal and ethical grounds 43,[74][75][76][77] .…”
Section: Social and Regulatory Challengesmentioning
confidence: 99%
See 1 more Smart Citation
“…One of the most critical questions is that although whole-genome sequencing of an individual's normal and tumor tissues can decipher what changes have occurred in both mtDNA and nuclear DNA, there is no model system currently available to evaluate the relevance of such changes. How mitochondrial function is altered in the presence of certain combinations of nuclear and mitochondrial genomes remains poorly understood and calls into question the safety of embryonic manipulations, including the three-parent baby (51). Furthermore, evolution may have preselected "compatible" mitochondrial and nuclear genomes to maximize function for survival (49); however, sequencing data argues that as mtDNA haplogroups coexist with divergent nuclear genomes in healthy individuals, "compatibility" is not an issue (16).…”
Section: Considerations and Unanswered Questionsmentioning
confidence: 99%